Clinical Trials Directory

Trials / Completed

CompletedNCT02691520

Epidemiology of Treatment Resistant Depression in Taiwan

Status
Completed
Phase
Study type
Observational
Enrollment
8,356 (actual)
Sponsor
Janssen Research & Development, LLC · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the epidemiology of Treatment Resistant Depression (TRD) in the nationally insured population in Taiwan including incidence, duration of clinical episodes, and prevalence by age and sex.

Detailed description

This is a retrospective study of approximately one million subjects randomly selected from an anonymized database National Health Insurance Research Database (NHIRD). Participants aged 18 years or older who have had neither a depression diagnosis nor a dispensing of an antidepressant medication in the last four months of 2004 will enter the study when they receive in 2005 a depression diagnosis and a dispensing of an antidepressant medication within 30 days of each other and will be followed up to 8 years or until they have 4 months with neither a depression diagnosis nor a dispensing of an antidepressant medication. Treatment Resistant Depression (TRD) Incidence, TRD prevalence by age and sex and duration of clinical episodes will be estimated.

Conditions

Timeline

Start date
2015-09-29
Primary completion
2016-02-18
Completion
2016-02-18
First posted
2016-02-25
Last updated
2024-10-28

Source: ClinicalTrials.gov record NCT02691520. Inclusion in this directory is not an endorsement.